Rise Advisors’s Smith & Wesson SWBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-73
Closed -$943 1212
2024
Q3
$943 Buy
73
+1
+1% +$14 ﹤0.01% 1165
2024
Q2
$1.03K Hold
72
﹤0.01% 1161
2024
Q1
$1.24K Buy
72
+1
+1% +$14 ﹤0.01% 1171
2023
Q4
$961 Sell
71
-99
-58% -$1.36K ﹤0.01% 524
2023
Q3
$2.2K Buy
170
+1
+0.6% +$12 ﹤0.01% 456
2023
Q2
$2.2K Sell
169
-159
-48% -$1.94K ﹤0.01% 504
2023
Q1
$4.04K Buy
328
+7
+2% +$75 ﹤0.01% 484
2022
Q4
$2.79K Buy
321
+3
+0.9% +$32 ﹤0.01% 517
2022
Q3
$3K Buy
318
+2
+0.6% +$26 ﹤0.01% 512
2022
Q2
$4K Hold
316
﹤0.01% 483
2022
Q1
$5K Buy
316
+98
+45% +$1.65K ﹤0.01% 435
2021
Q4
$3.89K Buy
+218
New +$4.5K ﹤0.01% 442

Other funds holding SWBI

Rise Advisors's SWBI Position: Q4 2024 in Review

Rise Advisors sold out of Smith & Wesson (SWBI) in Q4 2024, closing a stake of 73 shares — an estimated $943 sold.

Rise Advisors first reported a position in SWBI in Q4 2021 and held it in 12 quarters. The position peaked at $5K in Q1 2022. 182 funds tracked by Wall St. Rank hold SWBI as of Q4 2024.

  • Rise Advisors reported no remaining Smith & Wesson position as of Q4 2024 after selling out during the quarter.
  • Rise Advisors sold 73 Smith & Wesson shares in Q4 2024, an estimated $943.
  • Rise Advisors first reported a position in Smith & Wesson in Q4 2021 and held it in 12 quarters.
  • Rise Advisors's Smith & Wesson position peaked at $5K in Q1 2022.
  • 182 funds tracked by Wall St. Rank held Smith & Wesson as of Q4 2024.

Based on Rise Advisors's 13F filing for Q4 2024, filed 7 Jan 2025.